More and more consumers are looking for better sleep and more energy. Traditionally, NMN is known for boosting NAD+ levels and supporting healthy ageing.
UTHEVER® NMN Phase II human clinical study confirms it improve sleep. The study enrolled 34 adults aged 35–60 diagnosed with insomnia or mild sleep disorders.
PSQI sleep quality scores changed by 37%, indicating overall sleep improvement. Insomnia severity and fatigue scores dropped significantly (-48%), and continued to decline 1 month after stopping use, demonstrating sustained effects.
Download our new Anti-ageing White Paper to discover how UTHEVER® can work better in your healthy ageing or sleep products.
